LongCovid
„If you are high-risk, the answer is straightforward. If you are low-risk, there is less consensus.
Based on all of the recent findings, there is consensus that if you are at high risk, getting a vaccine booster at least annually, and possibly more frequently, continues to be valuable. For young, healthy people, though, the decision of when to get a booster, or whether to get one at all, is more individual.“
You can read this article published by the New York Times using the link below.
This emergency is not about to end. „Long COVID still lacks a universal clinical definition and a standard diagnosis protocol; there’s no consensus on its prevalence, or even what symptoms…
The H2020 PERISCOPE project investigates the broad socio-economic and behavioural impacts of the COVID-19 pandemic, to make Europe more resilient and prepared for future large-scale risks. Recently, the…
The first issue of the Long COVID newsletter is out now! Do not miss this opportunity to learn more about the project’s updates for the first 12 months of its…
The British Medical Association just published a very interesting paper showing the impact post-acute COVID symptoms on the medical workforce, personally and professionally in the UK. This publication…